Pembrolizumab-Induced Giant Cell Arteritis in the Setting of Urothelial Carcinoma-Reference-Cited by-同舟云学术

Pembrolizumab-Induced Giant Cell Arteritis in the Setting of Urothelial Carcinoma

Published:2022-09-07 Issue:2 Volume:47 Page:93-99
ISSN:0165-8107
Container-title:Neuro-Ophthalmology
language:en
Short-container-title:Neuro-Ophthalmology

Author:

Miano Deanna Ingrassia¹²^ORCID,Cosgrove Ryan¹²^ORCID,Sherman Joshua³,Balaraman Savitha⁴,Sherman Michael¹²

Affiliation:

1. Department of Ophthalmology, Ascension Eye Institute - Ascension Macomb-Oakland Hospital, Warren, Michigan, USA

2. Department of Neurology and Ophthalmology, Michigan State University, East Lansing, Michigan, USA

3. Lyman Briggs College, Michigan State University, East Lansing, Michigan, USA

4. Department of Oncology, Beaumont Health, Royal Oak, Michigan, USA

Funder

Ascension Macomb-Oakland Hospital

Publisher

Informa UK Limited

Subject

Neurology (clinical),Ophthalmology

Link

https://www.tandfonline.com/doi/pdf/10.1080/01658107.2022.2108847

Reference19 articles.

1. Highlights of prescribing information for Keytruda. Merck.com. Dec, 1 2021. www.merck.com/product/usa/pi_circulars/k/keytruda/keytruda_pi.pdf.

2. Merck provides update on KEYTRUDA® (Pembrolizumab) indication in metastatic small cell lung cancer in the US. Merck.com. Mar 1, 2021. www.merck.com/news/merck-provides-update-on-keytruda-pembrolizumab-indication-in-metastatic-small-cell-lung-cancer-in-the-us/.

3. Adverse Effects of Anti-PD-1/PD-L1 Therapy in Non-small Cell Lung Cancer

4. An unknown reaction to pembrolizumab: giant cell arteritis

5. “Giant cell arteritis manifesting as retinal arterial occlusion and paracentral acute middle maculopathy in a patient on pembrolizumab for metastatic uveal melanoma”

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pembrolizumab;Reactions Weekly;2023-04-08